Louis G. Lange, Director at Audentes Therapeutics, Inc. (BOLD), sold 31,000 shares at $37.45 ($1.2M) on 2018-09-24, disclosed to the SEC on 2018-09-26.
Open-market sale of $1.2M BOLD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.25 | 1,000 | $37K | 3.2% |
| 2 | $37.35 | 19,800 | $740K | 63.8% |
| 3 | $37.45 | 10,000 | $375K | 32.3% |
| 4 | $37.76 | 200 | $8K | 0.7% |
| Total | $37.38 avg | 31,000 | $1.2M | 100% |
| Filing → |
| NAMS | BUY | 2024-02-21 | $95K | — | Filing → |
| BOLD | SELL | 2019-12-27 | $656K | — | Filing → |
| BOLD | SELL | 2019-09-25 | $667K | — | Filing → |